FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to the pharmaceutical industry, in particular to a peroral pharmaceutical composition, which contains polysaccharides from platyclades of Opuntia Ficus Indica, an extract of Olea Europeae leaves, alginate and sodium bicarbonate in a specified ratio. Components of the composition described above act with respect to reduction of gastroesophageal reflux.
EFFECT: peroral pharmaceutical composition is intended for the prevention and treatment of gastroesophageal reflux and GERD.
4 cl, 9 tbl, 6 dwg
Title | Year | Author | Number |
---|---|---|---|
COMPOSITIONS FOR TREATING HAEMORRHOIDS AND ASSOCIATED DISEASES | 2010 |
|
RU2565397C2 |
METHOD OF ABATEMENT OF HEARTBURN AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) BY MEANS OF SPECIAL POLYSACCHARIDES | 2007 |
|
RU2432167C2 |
PHARMACEUTICAL COMPOSITION FOR TREATING GASTROESOPHAGEAL REFLUX DISEASE | 2012 |
|
RU2501549C1 |
ANTI-ULCEROUS PLANT COMPOSITION, METHOD FOR ITS OBTAINING AND APPLICATION | 2002 |
|
RU2302255C2 |
POWDER-LIKE ANTACIDE PHARMACEUTICAL COMPOSITION, PHARMACEUTICAL PREPARATION CONTAINING IT AND METHOD OF OBTAINING IT | 2007 |
|
RU2351332C2 |
METHOD FOR DETERMINING INDIVIDUAL INDICATIONS FOR SURGICAL MANAGEMENT OF PATIENTS WITH GASTROESOPHAGEAL REFLUX DISEASE | 2014 |
|
RU2545892C1 |
METHOD OF COMPLEX TREATMENT OF GASTROESOPHAGEAL DISEASE IN PATIENTS WITH OPISTHORCHOSIS | 2010 |
|
RU2420294C1 |
METHOD OF DIAGNOSTICS OF REFLUX TYPE WITH GASTROESOPHAGEAL REFLUX DISEASE | 2018 |
|
RU2671962C1 |
COMPOSITION FOR REDUCING ABSORPTION OF DIETARY FAT | 2011 |
|
RU2566050C2 |
PHARMACEUTICAL COMPOSITION FOR TREATING DISORDERS INCLUDING GASTROINTESTINAL IRRITATION | 2009 |
|
RU2497527C2 |
Authors
Dates
2014-07-27—Published
2010-01-15—Filed